Alector Announces First Patient Dosed in PROGRESS-AD Phase 2

SOUTH SAN FRANCISCO, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC) and GSK plc (LSE/NYSE: GSK) today announced that the...

Related Keywords

United States , South San Francisco , California , Katie Hogan , Arnon Rosenthal , Laura Perry , Dan Budwick , Nasdaq , Exchange Commission , Alector Inc , Chief Executive Officer , Clinical Dementia Rating Sum , Private Securities Litigation Reform Act , Quarterly Report ,